Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL01Antineoplastic agents
- Pharmacological subgroupL01F
- Chemical subgroupL01FF
- Chemical substanceL01FF07Dostarlimab
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Spain
AEMPS · 2 registrations
Brazil
Anvisa · 1 registration
Canada
Health Canada · 1 registration
European Union
EMA · 1 registration
At a glance
- ATC code
- L01FF07
- Registers
- 8
- Registrations
- 9
- With their own page
- 9
- Companies
- 6
All medicines with Dostarlimab
Human medicines from every register that match Dostarlimab by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
9 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Jemperli | United States | 500MG/10ML | injectable | Marketed | Glaxosmithkline |
| Jemperli | European Union | Authorised | GlaxoSmithKline Trading Services Limited | ||
| JEMPERLI 500 mg CONCENTRADO PARA SOLUCION PARA PERFUSION | Spain | 500 mg | concentrado para solución para perfusión | Marketed | Glaxosmithkline Trading Services Limited |
| Jemperli 500 MG Concentrado Para Solucion Para Perfusion | Spain | 500 mg | concentrado para solución para perfusión | Marketed | Glaxosmithkline (Ireland) Limited |
| Jemperli 500 mg oplossing voor infusie | Netherlands | Oplossing voor infusie | Authorised | GlaxoSmithKline Trading Services Limited | |
| Jemperli | Canada | 50 MG / ML | Solution | Marketed | Glaxosmithkline INC |
| Jemperli | Brazil | Authorised | Glaxosmithkline Brasil Ltda | ||
| Jemperli Concentrate for Solution for Infusion 500MG/10ML | Singapore | 500mg/10mL | infusion, solution concentrate | Authorised | Glaxosmithkline Pte LTD |
| Jemperli | Croatia | Marketed |